Literature DB >> 28149904

What the blood knows: interrogating circulating tumor DNA to predict progression of minimal residual disease in early breast cancer.

Melanie Majure1, Aaron C Logan1.   

Abstract

Entities:  

Year:  2016        PMID: 28149904      PMCID: PMC5233500          DOI: 10.21037/atm.2016.11.77

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  11 in total

1.  Breast Cancer Version 2.2015.

Authors:  William J Gradishar; Benjamin O Anderson; Ron Balassanian; Sarah L Blair; Harold J Burstein; Amy Cyr; Anthony D Elias; William B Farrar; Andres Forero; Sharon Hermes Giordano; Matthew Goetz; Lori J Goldstein; Clifford A Hudis; Steven J Isakoff; P Kelly Marcom; Ingrid A Mayer; Beryl McCormick; Meena Moran; Sameer A Patel; Lori J Pierce; Elizabeth C Reed; Kilian E Salerno; Lee S Schwartzberg; Karen Lisa Smith; Mary Lou Smith; Hatem Soliman; George Somlo; Melinda Telli; John H Ward; Dorothy A Shead; Rashmi Kumar
Journal:  J Natl Compr Canc Netw       Date:  2015-04       Impact factor: 11.908

2.  Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.

Authors:  Isaac Garcia-Murillas; Gaia Schiavon; Britta Weigelt; Charlotte Ng; Sarah Hrebien; Rosalind J Cutts; Maggie Cheang; Peter Osin; Ashutosh Nerurkar; Iwanka Kozarewa; Javier Armisen Garrido; Mitch Dowsett; Jorge S Reis-Filho; Ian E Smith; Nicholas C Turner
Journal:  Sci Transl Med       Date:  2015-08-26       Impact factor: 17.956

Review 3.  Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Lyndsay N Harris; Nofisat Ismaila; Lisa M McShane; Fabrice Andre; Deborah E Collyar; Ana M Gonzalez-Angulo; Elizabeth H Hammond; Nicole M Kuderer; Minetta C Liu; Robert G Mennel; Catherine Van Poznak; Robert C Bast; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2016-02-08       Impact factor: 44.544

4.  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Authors:  Fatima Cardoso; Laura J van't Veer; Jan Bogaerts; Leen Slaets; Giuseppe Viale; Suzette Delaloge; Jean-Yves Pierga; Etienne Brain; Sylvain Causeret; Mauro DeLorenzi; Annuska M Glas; Vassilis Golfinopoulos; Theodora Goulioti; Susan Knox; Erika Matos; Bart Meulemans; Peter A Neijenhuis; Ulrike Nitz; Rodolfo Passalacqua; Peter Ravdin; Isabel T Rubio; Mahasti Saghatchian; Tineke J Smilde; Christos Sotiriou; Lisette Stork; Carolyn Straehle; Geraldine Thomas; Alastair M Thompson; Jacobus M van der Hoeven; Peter Vuylsteke; René Bernards; Konstantinos Tryfonidis; Emiel Rutgers; Martine Piccart
Journal:  N Engl J Med       Date:  2016-08-25       Impact factor: 91.245

5.  Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.

Authors:  Jacqueline A Shaw; Karen Page; Kevin Blighe; Natasha Hava; David Guttery; Becky Ward; James Brown; Chetana Ruangpratheep; Justin Stebbing; Rachel Payne; Carlo Palmieri; Suzy Cleator; Rosemary A Walker; R Charles Coombes
Journal:  Genome Res       Date:  2011-10-11       Impact factor: 9.043

6.  Analysis of circulating tumor DNA to monitor metastatic breast cancer.

Authors:  Sarah-Jane Dawson; Dana W Y Tsui; Muhammed Murtaza; Heather Biggs; Oscar M Rueda; Suet-Feung Chin; Mark J Dunning; Davina Gale; Tim Forshew; Betania Mahler-Araujo; Sabrina Rajan; Sean Humphray; Jennifer Becq; David Halsall; Matthew Wallis; David Bentley; Carlos Caldas; Nitzan Rosenfeld
Journal:  N Engl J Med       Date:  2013-03-13       Impact factor: 91.245

7.  Free DNA in the serum of cancer patients and the effect of therapy.

Authors:  S A Leon; B Shapiro; D M Sklaroff; M J Yaros
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

8.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

Review 9.  American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

Authors:  Carolyn D Runowicz; Corinne R Leach; N Lynn Henry; Karen S Henry; Heather T Mackey; Rebecca L Cowens-Alvarado; Rachel S Cannady; Mandi L Pratt-Chapman; Stephen B Edge; Linda A Jacobs; Arti Hurria; Lawrence B Marks; Samuel J LaMonte; Ellen Warner; Gary H Lyman; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

10.  High-fidelity target sequencing of individual molecules identified using barcode sequences: de novo detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients.

Authors:  Yoji Kukita; Ryo Matoba; Junji Uchida; Takuya Hamakawa; Yuichiro Doki; Fumio Imamura; Kikuya Kato
Journal:  DNA Res       Date:  2015-06-29       Impact factor: 4.458

View more
  2 in total

1.  Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients.

Authors:  Pei Meng; Jiacong Wei; Yiqun Geng; Shaobin Chen; Miente Martijn Terpstra; Qiongyi Huang; Qian Zhang; Zuoqing Su; Wanchun Yu; Min Su; Klaas Kok; Anke van den Berg; Jiang Gu
Journal:  BMC Cancer       Date:  2019-08-20       Impact factor: 4.430

2.  Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma.

Authors:  Tao Liu; Qianqian Yao; Hai Jin
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.